Receptor Adaptation to Psychotropic Drugs

  • Jack W. Schweitzer
  • Kenneth A. Bonnet
  • Arnold J. Friedhoff


The membrane receptor is a site at which specific chemicals can regulate cell ular function; in turn, cells can regulate their sensitivity to many chemicals to compensate for persistent changes in agonist supply. The terms up- and down-regulation are used to describe shifts in receptor responsivity to drugs or to endogenous transmitters. Chronic antagonist administration, for example, can lead to a proliferation of receptor sites, a change viewed as an attempt by the cell to compensate for the loss of agonist resulting from the blockade by antagonist. In similar fashion, down-regulation can take place with chronic agonist oversupply. Thus, the receptor can act as both a regulated and regulatory unit. In this chapter an attempt is made to identify specific neuronal receptors that are acted on and ultimately altered by neuroleptics, antidepressants, and anxiolytic benzodiazepines and to discuss the application of receptor sensitivity modification (RSM) as a new approach to treatment of disorders that are responsive to alterations of CNS monoaminergic activity.


Adenylate Cyclase Psychotropic Drug Tardive Dyskinesia Tourette Syndrome Kainic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Seeman, P., 1980, Pharmacol. Rev. 32:229–313.PubMedGoogle Scholar
  2. 2.
    Burt, D. R., Creese, I., and Snyder, S. H., 1977, Science 196:326–328.PubMedGoogle Scholar
  3. 3.
    Clow, A., Jenner, P., Marsden, C. D., Murugaiah, K., and Theodorou, A., 1980, Proc. Br. Psychiatr. Soc. 242P.Google Scholar
  4. 4.
    Friedhoff, A. J., Bonnet, K., and Rosengarten, H., 1977, Res. Commun. Chem. Pathol. Pharmacol. 16:411–423.PubMedGoogle Scholar
  5. 5.
    Hyttel, J., 1978, Life Sci. 23:551–556.PubMedGoogle Scholar
  6. 6.
    Faustman, W., Fowler, S., and Walker, C., 1981, Eur. J. Pharmacol. 70:65–70.PubMedGoogle Scholar
  7. 7.
    Kobayashi, R. M., Fields, J. Z., Hruska, R. E., Beaumont, K., and Yamamura, H. I., 1977, Animal Models in Psychiatry and Neurology (I. Hanin and E. Usdin, eds.), Pergamon Press, New York, pp. 405–409.Google Scholar
  8. 8.
    Bacopoulos, N. G., 1981, Biochem. Pharmacol. 30:2037–2040.PubMedGoogle Scholar
  9. 9.
    Leysen, J. E., and Gommeren, W., 1981, J. Neurochem. 36:201–219.PubMedGoogle Scholar
  10. 10.
    Blaschke, E., and Hertting, G., 1971, Biochem. Pharmacol. 20:1363–1370.PubMedGoogle Scholar
  11. 11.
    Kayaalp, S. O., Rubenstein, J. S., and Neff, N. H., 1981, Neuropharmacology 20:409–410.Google Scholar
  12. 12.
    Zahniser, N. R., and Molinoff, P. B., 1978, Nature 275:453–455.PubMedGoogle Scholar
  13. 13.
    Scatchard, G., 1949, Ann. N.Y. Acad. Sci. 53:660–672.Google Scholar
  14. 14.
    Feldman, H. A., 1972, Anal. Biochem. 48:317–338.PubMedGoogle Scholar
  15. 15.
    Williams, L. T., and Lefkowitz, R. J., 1978, Receptor Binding Studies in Adrenergic Phar macology ,Raven Press, New York.Google Scholar
  16. 16.
    Yamamura, H. I., Enna, S. J., and Kuhar, M. J., 1978, Neurotransmitter Receptor Binding ,Raven Press, New York.Google Scholar
  17. 17.
    Sibley, D. R., and Creese, I., 1980, Eur. J. Pharmacol. 65:131–133.PubMedGoogle Scholar
  18. 18.
    Wehr, T. A., Wirz-Justice, A., Goodwin, F. K., Duncan, W., and Gillin, J. C., 1979, Science 206:710–713.PubMedGoogle Scholar
  19. 19.
    Cools, A. R., 1978, Life Sci. 23:2475–2484.PubMedGoogle Scholar
  20. 20.
    Naber, D., Wirz-Justice, A., Kafka, M. S., and Wehr, T. A., 1980, Psychopharmacology 68:1–5.PubMedGoogle Scholar
  21. 21.
    Naber, D., Wirz-Justice, A., Kafka, M. S., Tobler, I., and Borbely, A. A., 1981, Biol. Psychiatry 16:831–835.PubMedGoogle Scholar
  22. 22.
    Wirz-Justice, A., Kafka, M. S., Naber, D., and Wehr, T. A., 1980, Life Sci. 27:341–347.PubMedGoogle Scholar
  23. 23.
    Kafka, M. S., Wirz-Justice, A., Naber, D., and Wehr, T. A., 1981, Neuropharmacology 20:421–425.PubMedGoogle Scholar
  24. 24.
    Kafka, M. S., Wirz-Justice, A., and Naber, D., 1981, Brain Res. 207:409–419.PubMedGoogle Scholar
  25. 25.
    Codd, E. E., and Byrne, W. L., 1981, Life Sci. 28:2577–2583.PubMedGoogle Scholar
  26. 26.
    Schwartz, J.-C., Baudry, M., Martres, M.-P., Costentin, J., and Protais, P., 1978, Life Sci. 23:1785–1790.PubMedGoogle Scholar
  27. 27.
    Christensen, A. V., Fjalland, B., and Moller-Nielsen, I., 1976, Psychopharmacology 48:1–6.PubMedGoogle Scholar
  28. 28.
    Chiodo, L. A., and Antelman, S. M., 1980, Science 210:799–801.PubMedGoogle Scholar
  29. 29.
    Muller, P., and Seeman, P., 1978, Psychopharmacology 60:1–11.PubMedGoogle Scholar
  30. 30.
    Baldessarini, R. J., and Tarsy, D., 1978, Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killam, eds.), Raven Press, New York, pp. 993–1004.Google Scholar
  31. 31.
    Waddington, J. L., and Gamble, S. J., 1980, Eur. J. Pharmacol. 68:387–388.PubMedGoogle Scholar
  32. 32.
    Waddington, J. L., and Gamble, S. J., 1981, Lancet 1:1375.PubMedGoogle Scholar
  33. 33.
    Weiss, B., and Santelli, S., 1978, Science 200:799–801.PubMedGoogle Scholar
  34. 34.
    Weiss, B., Santelli, S., and Lusink, G., 1977, Psychopharmacologia 53:289.Google Scholar
  35. 35.
    Clow, A., Theodorou, A., Jenner, P., and Marsden, C. D., 1980, Eur. J. Pharmacol. 63:135–144.PubMedGoogle Scholar
  36. 36.
    Clow, A., Jenner, P., Theodorou, A., and Marsden, C. D., 1979, Nature 278:59–61.PubMedGoogle Scholar
  37. 37.
    Clow, A., Theodorou, A., Jenner, P., and Marsden, C. D., 1980, Eur. J. Pharmacol. 63:145–157.PubMedGoogle Scholar
  38. 38.
    Theodorou, A., Gommeren, W., Clow, A., Leysen, J., Jenner, P., and Marsden, C. D., 1981, Life Sci. 28:1621–1627.PubMedGoogle Scholar
  39. 39.
    Waddington, J. L., and Gamble, S. J., 1980, Psychopharmacology 71:75–77.PubMedGoogle Scholar
  40. 40.
    Waddington, J. L., Gamble, S. J., and Bourne, R. C., 1981, Eur. J. Pharmacol. 69:511–513.PubMedGoogle Scholar
  41. 41.
    Westerlink, B. H. C., and Horn, A. S., 1979, Eur. J. Pharmacol. 58:39–48.Google Scholar
  42. 42.
    Dawbarn, D., Long, S. K., and Pycock, C. J., 1980, Proc. Br. Psychiatr. Soc. 240P.Google Scholar
  43. 43.
    Kebabian, J. W., Chen, T. C., and Cote, T. E., 1979, Comm. Psychopharmacol. 3:421–428.Google Scholar
  44. 44.
    Gamble, S. J., and Waddington, J. L., 1980, Proc. Br. Psychiatr. Soc. 240P.Google Scholar
  45. 45.
    Dyer, R. G., Murugaiah, K., Theodorou, A., Clow, A., Jenner, P., and Marsden, C. D., mi, Life Sci. 28:167–174.Google Scholar
  46. 46.
    Owen, F., Cross, A. J., Waddington, J. L., Poulter, M., Gamble, S. J. and Crow, T. J., 1980, Life Sci. 26:55–59.PubMedGoogle Scholar
  47. 47.
    Cross, A. J., and Waddington, J. L., 1981, Eur. J. Pharmacol. 71:327–332.PubMedGoogle Scholar
  48. 48.
    Schwarcz, R., Creese, I., Coyle, J. T., and Snyder, S. H., 1978, Nature 271:766–768.PubMedGoogle Scholar
  49. 49.
    Euvrard, C., Premont, J., Oberlander, C., Boissier, J. R., and Bockaert, J., 1979, Naunyn Schmiedebergs Arch. Pharmacol. 309:241–245.PubMedGoogle Scholar
  50. 50.
    Marchais, D., and Bockaert, J., 1980, Biochem. Pharmacol. 29:1331–1336.PubMedGoogle Scholar
  51. 51.
    Stoof, J. C. and Kebabian, J. W., 1981, Nature 294:366–368.PubMedGoogle Scholar
  52. 52.
    Tsuruta, K., Frey, E. A., Grewe, C. W., Cote, T. E., Eskay, R. L., and Kebabian, J. W., 1981, Nature 292:463–465.PubMedGoogle Scholar
  53. 53.
    Pert, A., Rosenblatt, J. E., Sivit, C., Pert, C. B., Bunney, W. E. Jr., 1978, Science 201:171–173.PubMedGoogle Scholar
  54. 54.
    Gallager, D. W., Pert, A., and Bunney, W. E. Jr., 1978, Nature 273:309–312.PubMedGoogle Scholar
  55. 55.
    Meiler, E., and Friedman, E., 1981, Eur. J. Pharmacol. 76:25–29.Google Scholar
  56. 56.
    Staunton, D. A., Magistretti, P. J., Deyo, S. N., Shoemaker, W. J., and Bloom, F. E., 1981, Soc. Neurosci. Abstr. 7:163.Google Scholar
  57. 57.
    Ezrin-Waters, C., and Seeman, P., 1978, Life Sci. 22:1027–1032.PubMedGoogle Scholar
  58. 58.
    Tolis, C., Hickey, J., and Guyda, H., 1975, J. Clin. Endocrinol. Metab. 41:797.PubMedGoogle Scholar
  59. 59.
    Clemens, J. A., and Sawyer, B. D., 1974, Endocrine Res. Commun. 1:373.Google Scholar
  60. 60.
    Rossier, J., French, E., Rivier, C., Shibasaki, T., Guillemin, R., and Blood, F. E., 1980, Proc. Natl. Acad. Sci. U.S.A. 77:666–669.PubMedGoogle Scholar
  61. 61.
    Login, I. S., and MacLeod, R. M., 1979, Eur. J. Pharmacol. 60:253–255.PubMedGoogle Scholar
  62. 62.
    Belluzzi, J., and Stein, L., 1977, Nature 266:556–558.PubMedGoogle Scholar
  63. 63.
    Hong, J. S., Yang, H.-Y. T., Fratta, W., and Costa, E., 1978, J. Pharmacol. Exp. Ther. 205:141–147.PubMedGoogle Scholar
  64. 64.
    Moroni, F., Cheney, D. L., and Costa, E., 1977, Nature 267:267.PubMedGoogle Scholar
  65. 65.
    Risch, S. C., Cohen, R. M., Janowsky, D. S., Kalin, N. H., and Murphy, D. I., 1980, Science 209:1545–1546.PubMedGoogle Scholar
  66. 66.
    Hoffman, P. L., and Tabakoff, B., 1977, Nature 268:551–553.PubMedGoogle Scholar
  67. 67.
    Creese, I., and Sibley, D. R., 1981, Annu. Rev. Pharmacol. Toxicol. 21:357–391.PubMedGoogle Scholar
  68. 68.
    Puri, S. K., Spaulding, T. C., and Montione, C. R., 1978, Life Sci. 23:637–642.PubMedGoogle Scholar
  69. 69.
    Baume, S., Patey, G., Marcois, H., Protais, P., Costentin, J., and Schwartz, J.-C., 1979, Life Sci. 24:2333–2342.PubMedGoogle Scholar
  70. 70.
    Hruska, R. E., and Silbergeld, E. K., 1980, Eur. J. Pharmacol. 61:397–400.PubMedGoogle Scholar
  71. 71.
    Lozovsky, D., Sailer, C. F., and Kopin, I. J., 1981, Science 214:1031–1033.PubMedGoogle Scholar
  72. 72.
    Taylor, D. L., Ho, B. T., and Fagan, J. D., 1979, Commun. Psychopharmacol. 3:137–142.PubMedGoogle Scholar
  73. 73.
    Quik, M., and Iversen, L. L., 1979, Naunyn Schmiedebergs Arch. Pharmacol. 304:141–145.Google Scholar
  74. 74.
    Howlett, D. R., and Nahorski, S. R., 1979, Brain Res. 161:173–178.PubMedGoogle Scholar
  75. 75.
    Robertson, H. A., 1979, Soc. Neurosci. Abstr. 5:570.Google Scholar
  76. 76.
    Chiu, S., Paulose, C. S., and Mishra, R. K., 1981, Science 214:1261–1262.PubMedGoogle Scholar
  77. 77.
    Ritzmann, R. F., Walter, R., Bhargava, H. N., and Flexner, L. B., 1979, Proc. Natl. Acad. Sci. U.S.A. 76:5997–5998.PubMedGoogle Scholar
  78. 78.
    List, S., and Seeman, P., 1979, Life Sci. 24:1447–1452.PubMedGoogle Scholar
  79. 79.
    Vetulani, J., and Sulser, F., 1975, Nature 257:495–497.PubMedGoogle Scholar
  80. 80.
    Wolfe, B., Harden, T., Sporn, I., and Molinoff, P. B., 1978, J. Pharmacol. Exp. Ther. 207:446–457.PubMedGoogle Scholar
  81. 81.
    Mishra, R., Janowsky, A., and Sulser, F., 1979, Eur. J. Pharmacol. 60:379–382.PubMedGoogle Scholar
  82. 82.
    Baudry, M., Martres, M. P., and Schwartz, J.-C., 1976, Brain Res. 116:111–124.PubMedGoogle Scholar
  83. 83.
    Schmidt, M. J., and Thornberry, J. F., 1977, Arch. Int. Pharmacodyn. Ther. 229:42–51.PubMedGoogle Scholar
  84. 84.
    Leonard, B. E., 1978, Br. J. Pharmacol. 5:115–125.Google Scholar
  85. 85.
    Zis, A. P., and Goodwin, A. P., 1979, Arch. Gen. Psychiatry 36:1097.PubMedGoogle Scholar
  86. 86.
    Svensson, T., and Usdin, T., 1979, Catecholamine: Basic and Clinical Frontiers (E. Usdin, I. Kopir, and J. Barchas, eds.), Pergamon Press, New York, pp. 672–674.Google Scholar
  87. 87.
    Reisine, T. D., U’Prichard, D. C., Wiech, N., Ursillo, R., and Yamamura, H. I., 1980, Brain Res. 188:587–592.PubMedGoogle Scholar
  88. 88.
    Crews, F. T., and Smith, C. B., 1978, Science 202:322–324.PubMedGoogle Scholar
  89. 89.
    Reisine, T., 1981, Neuroscience 6:1471–1502.PubMedGoogle Scholar
  90. 90.
    Charney, D. S., Menkes, D. B., and Heninger, G. R., 1981, Arch. Gen. Psychiatry 38:1160–1180.PubMedGoogle Scholar
  91. 91.
    Mann, E., and Enna, S. J., 1980, Soc. Neurosci. Abstr. 6:800.Google Scholar
  92. 92.
    Tang, S. W., Seeman, P., and Kwan, S., 1980, Soc. Neurosci. Abstr. 6:861.Google Scholar
  93. 93.
    Blackshear, M. A., Steranke, R., and Sanders-Bush, E., 1980, Soc. Neurosci. Abstr. 6:860.Google Scholar
  94. 94.
    Bertilsson, L., Asberg, M., and Thoren, P., 1976, Eur. J. Clin. Pharmacol. 21:194–200.Google Scholar
  95. 95.
    Post, R. M., and Goodwin, F. K., 1974, Arch. Gen. Psychiatry 30:234–239.PubMedGoogle Scholar
  96. 96.
    Bowers, M. B., 1974, Clin. Pharmacol. Ther. 15:167–170.PubMedGoogle Scholar
  97. 97.
    Abrams, R., Essman, W. B., and Taylor, N. A., 1970, Biol. Psychiatry 11:85–90.Google Scholar
  98. 98.
    Kellar, K. J., Cascio, C. S., Butler, J. A., and Kurtzke, R. N., 1981, Eur. J. Pharmacol. 69:515–518.PubMedGoogle Scholar
  99. 99.
    Langer, S. Z., Moret, C., Raisman, R., Dubocovich, M. L., and Briley, M., 1980, Science 210:1133–1135.PubMedGoogle Scholar
  100. 100.
    Raisman, R., Briley, M., and Langer, S. Z., 1979, Eur. J. Pharmacol. 61:373–380.Google Scholar
  101. 101.
    Briley, M., Langer, S. Z., Raisman, R., Sechter, D., and Zarijian, E., 1980, Science 209:303–304.PubMedGoogle Scholar
  102. 102.
    Asarch, K. B., Shih, J. C., and Kulcsar, A., 1981, Soc. Neurosci. Abstr. 7:712.Google Scholar
  103. 103.
    Stanley, M., Virgilio, J., and Gershon, S., 1982, Science 216:1337–1339.PubMedGoogle Scholar
  104. 104.
    Dunbrille-Ross, A., and Tang, S. W., 1981, Soc. Neurosci. Abstr. 7:8.Google Scholar
  105. 105.
    Crews, F. T., Paul, S. M., and Goodwin, F. K., 1981, Nature 290:787–789.PubMedGoogle Scholar
  106. 106.
    Ursillo, R., Wiech, N., Reisine, T., and Yamamura, H. I., 1980, Psychopharmacology and Biochemistry of Neurotransmitter Receptors (H. I. Yamamura, R. W. Olson, and E. Usdin, eds.), Elsevier, Amsterdam, p. 189.Google Scholar
  107. 107.
    Schweitzer, J. W., Schwartz, R., and Friedhoff, A. J., 1979, J. Neurochem. 33:377–379.PubMedGoogle Scholar
  108. 108.
    Sarai, K., Frazer, A., Brunswick, D., and Mendels, J., 1978, Biochem. Pharmacol. 27:2179–2181.PubMedGoogle Scholar
  109. 109.
    Duman, R., Slopis, J., Kendall, D., and Enna, S. J., 1981, Soc. Neurosci. Abstr. 7:104.Google Scholar
  110. 110.
    Reinhard, J. F., and Roth, R. H., 1981, Soc. Neurosci. Abstr. 7:151.Google Scholar
  111. 111.
    Mobley, P. L., and Sulser, F., 1980, Nature 286:608–609.PubMedGoogle Scholar
  112. 112.
    Roberts, D. C. S., and Bloom, F. E., 1981, Eur. J. Pharmacol. 74:37–41.PubMedGoogle Scholar
  113. 113.
    Stone, E. A., 1979, Res. Commun. Psychol. Psychiatry Behav. 4:241–255.Google Scholar
  114. 114.
    Taylor, D. P., Allen, L. E., Ashworth, E. M., Becker, J. A., Hyslop, D. K., and Riblet, L. A., 1981, Neuropharmacology 20:513–516.PubMedGoogle Scholar
  115. 115.
    Johnson, R. W., Reisine, T., Spotnitz, S., Wiech, N., Ursillo, R., and Yamamura, H. I., 1980, Eur. J. Pharmacol. 67:123–127.PubMedGoogle Scholar
  116. 116.
    Basmann, H. B., 1978, FEBS. Lett. 87:199–202.Google Scholar
  117. 117.
    Mackerer, C., 1978, J. Pharmacol. Exp. Ther. 206:405–411.PubMedGoogle Scholar
  118. 118.
    Mohler, H., and Okada, T., 1978, Life Science 20:2101–2110.Google Scholar
  119. 119.
    Mohler, H., and Okada, T., 1977, Science 198:849–851.PubMedGoogle Scholar
  120. 120.
    Nielson, M., Braestrup, C., and Squires, R. F., 1978, Brain Res. 141:342–346.Google Scholar
  121. 121.
    Speth, R. C., and Wester, H., 1978, Life Sci. 22:859.PubMedGoogle Scholar
  122. 122.
    Speth, R. C., Wastek, C. J., and Yamamura, H. I., 1979, Life Sci. 24:351–358.PubMedGoogle Scholar
  123. 123.
    Lippa, A. S., Sano, M. C., Coupet, J., Kiepner, C. A., and Beer, B., 1978, Life Sci. 23:2213–2218.PubMedGoogle Scholar
  124. 124.
    Mallorga, P., Hamburg, M., Tallman, J. F., and Gallager, D. W., 1980, Neuropharmacology 19:405–408.PubMedGoogle Scholar
  125. 125.
    Thomas, J., Yousufi, M., and Tallman, J., 1979, Soc. Neurosci. Abstr. 5:2269.Google Scholar
  126. 126.
    Gavish, M., and Snyder, S. H., 1980, Life Sci. 26:579–582.PubMedGoogle Scholar
  127. 127.
    Sieghart, W., and Karobath, M., 1980, Nature 286:285–287.PubMedGoogle Scholar
  128. 128.
    Squires, R., Benson, D. I., Braestrup, C., Coupet, J., and Kiepner, C. A., 1979, Pharm. Biochem. Behav. 10:825–839.Google Scholar
  129. 129.
    Lippa, A. S., Critchett, D. J., Sano, M. C., Kiepner, C. A., Greenblatt, E. N., Coupet, J., and Beer, B., 1979, Pharmacol. Biochem. Behav. 10:831–843.PubMedGoogle Scholar
  130. 130.
    Skolnick, P., Marangos, P., Syapin, P., Goodwin, F., and Paul, S., 1979, Pharmacol. Biochem. Behav. 10:815–823.PubMedGoogle Scholar
  131. 131.
    Meyerson, L. R., Sano, M. C., Critchett, D. J., Beer, B., and Lippa, A. S., 1981, Eur. J. Pharmacol. 71:147–150.PubMedGoogle Scholar
  132. 132.
    Biggio, G., Corda, M. G., and Gessa, G. L., 1981, Brain Res. 220:344–349.PubMedGoogle Scholar
  133. 133.
    Lloyd, K. G., Shemen, L., and Hornykiewicz, O., 1977, Brain Res. 127:269–275.Google Scholar
  134. 134.
    Rinne, U. K., Koskinen, V., Laaksonen, H., Lonnberg, P., and Sonninen, V., 1978, Life Sci. 22:2225–2228.PubMedGoogle Scholar
  135. 135.
    Lloyd, K. G., Dreksler, S., and Bird, E. D., 1977, Life Sci. 21:747–754.PubMedGoogle Scholar
  136. 136.
    Olsen, R. W., Van Ness, P. C., Napias, C., Bergman, M., and Tourtellette, W. W., 1980, Adv. Biochem. Psychopharmacol. 21:451–460.PubMedGoogle Scholar
  137. 137.
    Enna, S. J., Bennett, J. P., Bylund, D. B., Snyder, S. H., Bird, E. D., and Iversen, L. L., 1976, Brain Res. 116:531–537.PubMedGoogle Scholar
  138. 138.
    Waddington, J. L., Cross, A. J., 1980, Brain Res. Bull. 5(Suppl. 2):825–828.Google Scholar
  139. 139.
    Davis, L. G., and Cohen, R. K., 1980, Biochem. Biophys. Res. Commun. 92:141–148.PubMedGoogle Scholar
  140. 140.
    Marangos, P. J., Paul, S. M., Goodwin, F. S., Syapin, P., and Skolnick, P., 1979, Life Sci. 24:851–858.PubMedGoogle Scholar
  141. 141.
    Marangos, P. J., Martino, A. M., Paul, S., and Skolnick, P., 1981, Psychopharmacology 72:269–273.PubMedGoogle Scholar
  142. 142.
    Anderson, L. T., David, R., Bonnet, K. A., and Dancis, J., 1979, Life Sci. 24:905–910.PubMedGoogle Scholar
  143. 143.
    Chiu, T. H., and Rosenberg, H. C., 1979, Eur. J. Pharmacol. 56:337–345.PubMedGoogle Scholar
  144. 144.
    Schlosger, W., and Franco, S., 1979, J. Pharmacol. Exp. Ther. 21:290–295.Google Scholar
  145. 145.
    Hunkeler, W., 1981, Nature 290:514–516.PubMedGoogle Scholar
  146. 146.
    Guidotti, A., Massotti, M., and Costa, E., 1980, Psychopharmacology and Biochemistry of Neurotransmitter Receptors ,(H. I. Yamamura, R. W. Olsen, and E. Usdin, eds.), Elsevier, Amsterdam, New York, pp. 655–660.Google Scholar
  147. 147.
    Saano, V., Urtti, A., and Airaksinen, M. M., 1981, Pharmacol. Res. Commun. 13:75–85.PubMedGoogle Scholar
  148. 148.
    Simantov, R., Oster-Granite, M. L., Herndon, R. M., and Snyder, S. H., 1976, Brain Res. 105:365–371.PubMedGoogle Scholar
  149. 149.
    Shibuya, H., Gale, K., and Pert, C. B., 1980, Eur. J. Pharmacol. 62:243–244.PubMedGoogle Scholar
  150. 150.
    Kellogg, C., Tervo, D., Ison, J., and Parisi, T., 1980, Science 207:205–207.PubMedGoogle Scholar
  151. 151.
    Rosengarten, H., and Friedhoff, A. J., 1979, Science 203:1133–1135.PubMedGoogle Scholar
  152. 152.
    Friedhoff, A. J., 1977, Comp. Psychiatry 18:309–317.Google Scholar
  153. 153.
    Friedhoff, A. J., and Alpert, M., 1978, Psychopharmacology: A Generation of Progress (M. Lipton, A. DiMascio and K. F. Killam, eds.), Raven Press, New York, pp. 797–801.Google Scholar
  154. 154.
    Alpert, M., and Friedhoff, A. J., 1980, Tardive Dyskinesia: Research and Treatment (W. E. Fann, J. M. Davis, R. C. Smith, and E. F. Domino, eds.), Spectrum, New York, pp. 471– 474.Google Scholar
  155. 155.
    Alpert, M., Friedhoff, A. J., Marcos, L. R., and Diamond, F., 1978, Am. J. Psychiatry 135:1329–1332.PubMedGoogle Scholar
  156. 156.
    Yaryura-Tobias, J. A., Wolpert, A., Dana, L., and Merlis, S., 1970, Dis. Nerv. Syst. 31:60–63.PubMedGoogle Scholar
  157. 157.
    Beramendi, V., Alpert, M., Guimon, J., Friedhoff, A. J., and Gutierrez, M., 1980, Arch. Neurobiol. 43:107–124.Google Scholar
  158. 158.
    Gutierrez, M., Alpert, M., Guimon, M., Friedhoff, A. J., and Bermendi, V., 1979, Infor maciones Psiquiatricas 2º-Trimestre ,No. 75, Barcelona, pp. 99–107.Google Scholar
  159. 159.
    Alpert, M., Friedhoff, A. J., and Diamond, F., 1983, in Advances in Neurology, Vol. 37: Experimental Therapeutics of Movement Disorders (S. Fahn, D. B. Calne, and I. Shoulson, eds.), Raven Press, New York, pp. 253–258.Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Jack W. Schweitzer
    • 1
  • Kenneth A. Bonnet
    • 1
  • Arnold J. Friedhoff
    • 1
  1. 1.Department of Psychiatry, Millhauser LaboratoriesNew York University School of MedicineNew YorkUSA

Personalised recommendations